NAMS analyst estimates

NewAmsterdam Pharma (NAMS) analyst ratings, the average price target and its range, and every firm's latest call.

• 0 firms rate NAMS: 0 buy, 0 hold, 0 sell.

Updated 2026-11-07 11:52 UTC